Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Feb 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1940761000001115 | Seffalair Spiromax 12.75micrograms/dose / 100micrograms/dose dry powder inhaler (Teva UK Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1940771000001113 | Seffalair Spiromax 12.75micrograms/dose / 100micrograms/dose dry powder inhaler (Teva UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Seffalair Spiromax 12.75micrograms/dose / 100micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose | Has AMP | True | Seffalair Spiromax 12.75micrograms/dose / 100micrograms/dose dry powder inhaler (Teva UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets